Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis
Anne L. Ashford, Daniela Nachmanson, John W. Wills, Jacob E. Higgins, Thomas Horace Smith, Kevin C. Vavra, Farah A. Dahalan, Jonathan Howe, Joanne M. Elloway, Jesse J. Salk, Ann Doherty, Anthony M. Lynch
This study aligns Duplex Sequencing with transgenic rodent mutation assay data to assess in vivo NDMA-induced mutagenesis, finding dose-dependent mutation frequency increases and concordant benchmark dose estimates.
Archives of Toxicology · Jul 17, 2025Peer-reviewedPharmacology & Toxicology